GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 97 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2016. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,048,000 | +116.7% | 103,490 | +1.6% | 0.02% | +114.3% |
| Q2 2022 | $3,252,000 | +38.8% | 101,811 | +27.2% | 0.01% | +75.0% |
| Q4 2021 | $2,343,000 | +213.7% | 80,042 | +173.1% | 0.00% | +33.3% |
| Q3 2021 | $747,000 | -89.9% | 29,307 | -78.1% | 0.00% | -93.6% |
| Q3 2020 | $7,382,000 | -47.3% | 133,872 | -39.6% | 0.05% | -52.0% |
| Q2 2020 | $14,001,000 | +33.8% | 221,786 | -69.4% | 0.10% | +42.0% |
| Q4 2016 | $10,462,000 | – | 724,024 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 355,509 | $17,171,000 | 9.58% |
| Perceptive Advisors | 4,989,066 | $240,971,000 | 6.75% |
| GREAT POINT PARTNERS LLC | 736,631 | $35,579,000,000 | 5.28% |
| Casdin Capital, LLC | 600,000 | $28,980,000 | 5.10% |
| Avoro Capital Advisors LLC | 1,765,548 | $85,276,000 | 4.07% |
| Iguana Healthcare Management, LLC | 115,000 | $5,555,000 | 3.65% |
| Camber Capital Management LP | 1,200,000 | $57,960,000 | 2.85% |
| NEXTHERA CAPITAL LP | 315,147 | $15,222,000 | 2.51% |
| RTW INVESTMENTS, LP | 456,921 | $22,069,000 | 2.10% |
| EMORY UNIVERSITY | 41,610 | $2,010,000 | 1.44% |